PK

Peter Kuhn

Director Director DIN 02897182
DIN 02897182 First appointment Apr 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2004
Shareholding value Locked Premium profile

About Peter Kuhn

Data last updated:

Peter Kuhn has 22 years in corporate governance. Formerly with 1 company, such as Murli Krishna Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02897182
Primary Designation Director
First Appointment 02 Apr 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Murli Krishna Pharma Private Limited U24230PN2004PTC206917
Director02 Apr 20042004Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Murli Krishna Pharma Private Limited
Premium access

Shareholding and investment profile for Peter Kuhn

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peter Kuhn

Peter Kuhn has 22 years in corporate governance. Formerly with 1 company, such as Murli Krishna Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Peter Kuhn is associated with 0 companies as a director.

Peter Kuhn has expertise in General Business.

Peter Kuhn has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available